USFDA completes inspection at Jubilant Pharmova’s arm’s solid oral formulations facility at Salisbury

17 Jan 2025 Evaluate

United States Food and Drug Administration (USFDA) has completed inspection at Jubilant Pharmova’s subsidiary -- Jubilant Cadista Pharmaceuticals Inc., (Jubilant Cadista)’s solid oral formulations facility at Salisbury, Maryland.  

USFDA has issued five observations with no repeat observations. Jubilant Cadista will submit an appropriate action plan to the USFDA on these observations within stipulated time. Going forward, the said facility is not expected to manufacture any products as it has closed manufacturing operations as was referenced in the previous disclosure dated April 18, 2024.

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.


Jubilant Pharmova Share Price

914.40 21.70 (2.43%)
01-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.95
Dr. Reddys Lab 1152.40
Cipla 1444.55
Lupin 1956.40
Zydus Lifesciences 877.50
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...